KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Assets (2016 - 2025)

Historic Return on Assets for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.05%.

  • Emergent BioSolutions' Return on Assets rose 1900.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.12% for FY2024, which is 1900.0% up from last year.
  • Per Emergent BioSolutions' latest filing, its Return on Assets stood at 0.05% for Q3 2025, which was up 1900.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Assets registered a high of 0.13% during Q1 2021, and its lowest value of 0.41% during Q4 2023.
  • In the last 5 years, Emergent BioSolutions' Return on Assets had a median value of 0.07% in 2022 and averaged 0.09%.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -3900bps in 2023, then surged by 4500bps in 2025.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Return on Assets stood at 0.08% in 2021, then crashed by -194bps to 0.07% in 2022, then crashed by -479bps to 0.41% in 2023, then surged by 68bps to 0.13% in 2024, then skyrocketed by 140bps to 0.05% in 2025.
  • Its Return on Assets stands at 0.05% for Q3 2025, versus 0.1% for Q2 2025 and 0.09% for Q1 2025.